www.secnews.physaphae.fr This is the RSS 2.0 feed from www.secnews.physaphae.fr. IT's a simple agragated flow of multiple articles soruces. Liste of sources, can be found on www.secnews.physaphae.fr. 2024-05-13T01:37:05+00:00 www.secnews.physaphae.fr We Live Security - Editeur Logiciel Antivirus ESET Les paiements de ransomwares ont atteint un record en 2023 & # 8211;Semaine en sécurité avec Tony Anscombe<br>Ransomware payments hit a record high in 2023 – Week in security with Tony Anscombe Called a "watershed year for ransomware", 2023 marked a reversal from the decline in ransomware payments observed in the previous year]]> 2024-02-09T13:46:14+00:00 https://www.welivesecurity.com/en/videos/ransomware-payments-record-week-security-tony-anscombe/ www.secnews.physaphae.fr/article.php?IdArticle=8448650 False Ransomware,Studies None 4.0000000000000000 We Live Security - Editeur Logiciel Antivirus ESET Résultats clés du rapport de la menace ESET H2 2023 & # 8211;Semaine en sécurité avec Tony Anscombe<br>Key findings from ESET Threat Report H2 2023 – Week in security with Tony Anscombe How cybercriminals take advantage of the popularity of ChatGPT and other tools of its ilk to direct people to sketchy sites, plus other interesting findings from ESET\'s latest Threat Report]]> 2023-12-22T10:50:20+00:00 https://www.welivesecurity.com/en/videos/key-findings-eset-threat-report-h2-2023-week-security-tony-anscombe/ www.secnews.physaphae.fr/article.php?IdArticle=8427789 False Tool,Threat,Studies ChatGPT 4.0000000000000000 We Live Security - Editeur Logiciel Antivirus ESET Key findings from ESET Threat Report H1 2023 – Week in security with Tony Anscombe Here\'s how cybercriminals have adjusted their tactics in response to Microsoft\'s stricter security policies, plus other interesting findings from ESET\'s new Threat Report]]> 2023-07-14T13:30:00+00:00 https://www.welivesecurity.com/en/videos/key-findings-eset-threat-report-h1-2023-week-security-tony-anscombe/ www.secnews.physaphae.fr/article.php?IdArticle=8382253 False Threat,Studies,Medical None 4.0000000000000000